why choose us

First received: November 07, 2023

Clinical Trial: Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate

Study Status: Completed

Recruit Status: RECRUITING

Condition: Respiratory Syncytial Virus Infection

Study Type: INTERVENTIONAL


Official Title: A Phase I/IIa, Randomized, Observer-blind Placebo-controlled Multi-arm Study to Evaluate the Safety and Immunogenicity of an RSV/hMPV Vaccine, in Adult Participants Aged 60 Years and Older

Brief Summary: The purpose of this study is to assess the safety and immunogenicity of a single intramuscular (IM) injection of different doses of an respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) vaccine candidate, in adult participants aged 60 years and older.In addition, the study will evaluate the safety and immunogenicity of a booster vaccination administered 12 months after the primary vaccination in a subset of the study population.

Read more